M4MM
Massachusetts Ballot to Decide on Psychedelics Legalization in November
LOS ANGELES- Massachusetts voters are set to decide on a significant measure this November with Question 4, a ballot initiative to legalize certain plant-based psychedelics, including psilocybin, mescaline, and dimethyltryptamine (DMT). If approved, Massachusetts would ...
France: The Investment Landscape of the Medical Cannabis Sector
PARIS — Encouraged by the advances of Germany, the investment climate in France's medical cannabis industry is evolving on a promising trajectory, marked by a transition from a history of strict prohibition and stigma to ...
Cannabis Opportunities in Germany: Positive Outlook for Investment and Innovation
BERLIN — The investment climate in Germany's cannabis market is poised for significant expansion, driven by the global cannabis legalization movement, ongoing regulatory changes, and mounting community and market demand. As the country embraces a ...
Few Pardons Issued for Cannabis Crimes in Canada Since 2019 Reforms
LOS ANGELES- Despite the federal government’s estimate that 10,000 Canadians would be eligible for conviction relief following the legalization of cannabis in 2018, only 845 pardons have been granted since 2019. Data from the Parole ...
South Africa Legalizes Cannabis for Personal Use
LOS ANGELES- South Africa has become the first country in Africa to legalize cannabis for personal use. The Cannabis for Private Purposes Act was signed into law by President Cyril Ramaphosa on May 28, just ...
Red Light Holland Completes Initial Phase of Psilocybin Extraction
LOS ANGELES- Red Light Holland Corp. a company specializing in the production and sale of functional mushrooms and psilocybin truffles, announced the successful completion of the first phase of psilocybin extraction. This milestone was achieved ...
Optimi Health to Export MDMA and Psilocybin Capsules to Australia
LOS ANGELES- a Health Canada licensed GMP psychedelics pharmaceutical manufacturer, announced it has received an import permit from Mind Medicine Australia (MMA) to supply its GMP MDMA and psilocybin capsules to approved psychiatrists under Australia’s ...
Massachusetts Ballot to Decide on Psychedelics Legalization in November
LOS ANGELES- Massachusetts voters are set to decide on a significant measure this November with Question 4, a ballot initiative to legalize certain plant-based psychedelics, including psilocybin, mescaline, and dimethyltryptamine (DMT). If approved, Massachusetts would ...
France: The Investment Landscape of the Medical Cannabis Sector
PARIS — Encouraged by the advances of Germany, the investment climate in France's medical cannabis industry is evolving on a promising trajectory, marked by a transition from a history of strict prohibition and stigma to ...
Cannabis Opportunities in Germany: Positive Outlook for Investment and Innovation
BERLIN — The investment climate in Germany's cannabis market is poised for significant expansion, driven by the global cannabis legalization movement, ongoing regulatory changes, and mounting community and market demand. As the country embraces a ...
Khiron Announces Intention to Renew its Normal Course Issuer Bid
TORONTO - Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQX: KHRNF) , (Frankfurt: A2JMZC), a vertically integrated cannabis company with operations in Latin America and Europe, announced today its intention to renew its prior normal course ...
The Valens Company Enters White Label Partnership with Fire & Flower, a Canadian Cannabis Retailer
KELOWNA, BC - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) , a manufacturer of cannabis products, announced a white label partnership with Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF), a technology-powered, cannabis ...
